Comprehensively mapping and decoding the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
| Website | http://immunai.com |
| Revenue | $29.4 million |
| Employees | 173 (152 on RocketReach) |
| Founded | 2019 |
| Address | 180 Varick Street, New York, New York, US |
| Phone | +1 727-543-2286 |
| Technologies |
JavaScript
,
HTML
,
PHP
+33 more
(view full list)
|
| Industry | Biotechnology Research, Analytics, Biotechnology, Data and Analytics, Artificial Intelligence, Science and Engineering, Software |
| Keywords | Cell Therapy, Artificial Intelligence, Immune System, Ai Drug Discovery, Biotechnology Research, Therapeutic Discovery, Precision Medicine, Immunotherapy, Biotechnology, Drug Development, Machine Learning, Data-Driven Healthcare, Patient Outcomes, Clinical Trials, Bioinformatics, Genomics, Immunology Research, Pharmaceutical Research, Healthcare Technology |
| Competitors | Bristol Myers Squibb, Illumina, Tempus Labs, Inc., Guardant Health, GRAIL, Foundation Medicine, 10x Genomics, Adaptive Biotechnologies Corp., Cell Signaling Technology (CST), Cellarity +45 more (view full list) |
Looking for a particular Immunai employee's phone or email?
Immunai Questions
The Immunai annual revenue was $29.4 million in 2026.
Noam Solomon is the CEO of Immunai.
152 people are employed at Immunai.
Immunai is based in New York, New York.
Top Immunai Employees
-
Noam Solomon
Chief Executive Officer at Immunai
Tel Aviv-Yafo, IL23 -
Daniel Cohen
Chief Operations Officer at Immunai
New York, NY, US24 -
Ethan Grant
Vice President, Therapeutics Discovery at Immunai
Cambridge, MA, US22 -
2
-
3
-
Danielle Galanaugh
Director, HRBP at Immunai
New York, NY, US12 -
Eleni Mimitou
Director, Molecular Profiling at Immunai
New York, NY, US21 -
Priyanka Vijay
Associate Director at Immunai
New York, NY, US1
Related Companies
G2Crowd Trusted
300K+
Plugin Users
